CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Maintenance of health-related quality of life in elderly patients treated with ribociclib + letrozole in MONALEESA-2.
Author
Anne Favret
Carlos A. Alemany
+10Â more
D. Das Purkayastha
David Chandiwana
Gabriel N. Hortobagyi
Gena H. Volas-Redd
Howard A. Burris
Johan Baeck
Lowell L. Hart
Mikhail Shtivelband
Nicola Caria
Sara M. Tolaney
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
METRIC: A randomized international study of the antibody-drug conjugate glembatumumab vedotin (GV or CDX-011) in patients (pts) with metastatic gpNMB-overexpressing triple-negative breast cancer (TNBC).
Author
Alberto J. Montero
Andres Forero
+16Â more
Brooke R. Daniel
Catherine Angela Oakman
Christopher D. Turner
Cristiano Ferrario
Denise A. Yardley
Gena H. Volas-Redd
Helen K. Chew
Linda T. Vahdat
Lynn Aneiro
Michelle E. Melisko
Norah Lynn Henry
Robyn R. Young
Thomas A. Davis
Troy H. Guthrie
Vikki A. Canfield
Yi He
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study
Author
Aaronson
Anand A. Dalal
+47Â more
Anne Favret
Bhuvaneswari Ramaswamy
Carlos Alemany
Chung
Cristina I. Truica
Cristofanilli
Das Purkayastha
Denise A. Yardley
Donald Richards
Eisenhauer
Finn
Francisco J. Esteva
Gabriel N. Hortobagyi
Gelmon
Gena Volas-Redd
Goetz
Guimarães
Hahn
Hortobagyi
Hortobagyi
J. Thad Beck
Joseph Sparano
Kimberly Blackwell
Levit
Lowell Hart
Mariotto
Michaela Tsai
Michelle Miller
Mikhail Shtivelband
Mouridsen
Nabholtz
Oken
O’Shaughnessy
Paridaens
Patrick Ward
Paul Richards
Ribeiro-Vaz
Rugo
Sami Diab
Sara M. Tolaney
Shim
Sibel Blau
Sledge
Smith
Sonke
Timothy Pluard
Yusuf
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma
Author
Anita Mahajan
Bozic
+54Â more
Brandes
Brandsma
Butowski
Chang
Charles A. Conrad
Chowdhary
Cloughesy
Eric L. Chang
Fine
Flaherty
Gena Volas-Redd
Gilbert
Gilbert
Green
Howard Colman
Jaeckle
Javier Gonzalez
John F. De Groot
Joki
Justin D. Floyd
Kang
Kenneth D. Aldape
Kenneth R. Hess
Kruser
Lore W. Lagrone
Macdonald
Mark R. Gilbert
Marta Penas-Prado
McAlister
Michael E. Salacz
Michael J. Fisch
Monica E. Loghin
Montgomery
Morris D. Groves
Penas-Prado
Perry
Pierre Giglio
See
Shiao Y. Woo
Shono
Short
Sigmund H. Hsu
Stupp
Stupp
Taal
Tolcher
Victor A. Levin
Vinay K. Puduvalli
W. K. Alfred Yung
Wick
Wick
Woodcock
Yung
Yung
Publication venue
'Oxford University Press (OUP)'
Publication date
Field of study
No full text
Crossref